Allergan CEO: Emerging Customers | Mad Money | CNBC

Allergan reported terrific earnings, but the stock remained stagnant. Is the Botox-maker frozen, or is now the time to buy? Jim Cramer eyed the fine lines of its latest earnings report with the CEO.
» Subscribe to CNBC:
» Watch more Mad Money here:
» Read more about Allergan here:
"Mad Money" takes viewers inside the mind of one of Wall Street's most respected and successful money managers. Jim Cramer is your personal guide through the confusing jungle of Wall Street investing, navigating through both opportunities and pitfalls with one goal in mind -- to try to help you make money.

About CNBC: From 'Wall Street' to 'Main Street' to award winning original documentaries and Reality TV series, CNBC has you covered. Experience special sneak peeks of your favorite shows, exclusive video and more.

Get More Mad Money!
Read the latest news:
Watch full episodes:
Follow Mad Money on Twitter:
Like Mad Money on Facebook:
Follow Cramer on Twitter:

Connect with CNBC News Online!
Find CNBC News on Facebook:
Follow CNBC News on Twitter:
Follow CNBC News on Google+:
Follow CNBC News on Instagram:

Allergan CEO: Emerging Customers | Mad Money | CNBC

(Source: CNBC (via YouTube))